|
TAF13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.88869999995234E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.32690000000679E-05 |
| Normal-vs-Stage2 |
1.958350E-03 |
| Normal-vs-Stage3 |
1.70209999994508E-06 |
| Normal-vs-Stage4 |
2.01639999999337E-05 |
| Stage1-vs-Stage2 |
9.461800E-01 |
| Stage1-vs-Stage3 |
1.432420E-01 |
| Stage1-vs-Stage4 |
1.107390E-01 |
| Stage2-vs-Stage3 |
2.871200E-01 |
| Stage2-vs-Stage4 |
1.957420E-01 |
| Stage3-vs-Stage4 |
6.496000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.16920000003962E-06 |
| Normal-vs-AfricanAmerican |
1.533190E-01 |
| Normal-vs-Asian |
4.009100E-04 |
| Caucasian-vs-AfricanAmerican |
1.230970E-01 |
| Caucasian-vs-Asian |
7.899400E-01 |
| AfricanAmerican-vs-Asian |
1.903020E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.95540000039685E-08 |
| Normal-vs-Female |
5.57439999999687E-05 |
| Male-vs-Female |
2.241700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.398900E-04 |
| Normal-vs-Age(41-60Yrs) |
1.88679999957309E-07 |
| Normal-vs-Age(61-80Yrs) |
1.97849999999944E-05 |
| Normal-vs-Age(81-100Yrs) |
1.248640E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.002300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.015000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.927800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.461200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.340600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.150400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.368630E-01 |
| Classical-VS-Follicular |
1.719560E-01 |
| Classical-VS-Other |
1.070610E-01 |
| Classical-VS-Normal |
1.227690E-04 |
| Tall-VS-Follicular |
5.772400E-01 |
| Tall-VS-Other |
3.638800E-01 |
| Tall-VS-Normal |
1.173840E-04 |
| Follicular-VS-Other |
2.562400E-01 |
| Follicular-VS-Normal |
3.57939999999779E-05 |
| Other-VS-Normal |
2.598600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.44150000003229E-06 |
| Normal-vs-N1 |
9.72009999999912E-05 |
| N0-vs-N1 |
5.291000E-01 |
|
|
